Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy

奥沙利铂 免疫检查点 医学 癌症研究 肝细胞癌 CD8型 免疫疗法 体内 封锁 抗体 免疫原性细胞死亡 免疫系统 免疫学 细胞毒性T细胞 癌症 结直肠癌 生物 内科学 体外 受体 生物化学 生物技术
作者
Hanzhang Zhu,Yuqiang Shan,Ke Ge,Jun Lü,Wencheng Kong,Changku Jia
出处
期刊:Cellular oncology [Springer Nature]
卷期号:43 (6): 1203-1214 被引量:154
标识
DOI:10.1007/s13402-020-00552-2
摘要

Hepatocellular carcinoma (HCC) is one of the most common and devastating malignancies. Oxaliplatin, a platinum-based chemotherapeutic agent, is approved for the treatment of several malignancies, including HCC. However, its role in HCC is not well established. This study was designed to investigate the potential of oxaliplatin as an immunogenic cell death (ICD) inducer and to explore its regulatory effects on the response of HCC to immune checkpoint blockade therapy. Murine and human HCC cells were treated with oxaliplatin, followed by evaluation of the expression of ICD-related biomarkers. Murine HCC cells (H22) were subcutaneously inoculated into mice to establish a syngeneic tumor graft model, after which tumor sizes and in vivo immune cell activation were evaluated. To assess putative synergistic effects of oxaliplatin with anti-PD-1 antibodies on H22 tumors, tumor parameters and secreted cytokines were quantified. ICD-related biomarkers were found to be enhanced after treatment of human and murine HCC cells with oxaliplatin. Additionally, we found that the number of mature dendritic cells (DCs) was increased after immature DCs were cocultured with oxaliplatin-treated H22 cells. The numbers of CD8+ T cells and mature DCs were found to be increased in vivo whereas, in contrast, the number of Treg cells was decreased. The tumor sizes were smaller in the oxaliplatin group than in the control group. In the syngeneic tumor graft model, we found that combination therapy with oxaliplatin and anti-PD-1 antibodies could achieve better outcomes than monotherapy, as indicated by (i) inhibition of tumor growth and TGF-β secretion and (ii) augmentation of inflammatory cytokine secretion. Our data indicate that oxaliplatin can be used as an inducer of ICD and as a modulator of the tumor immune microenvironment. Combination therapies composed of oxaliplatin and immune checkpoint inhibitors may open up novel avenues for the treatment of HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
KEYANGOU完成签到,获得积分10
刚刚
朴实的冰菱完成签到 ,获得积分10
刚刚
1秒前
顺心人达发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
赤壁发布了新的文献求助10
3秒前
林余发布了新的文献求助20
3秒前
4秒前
4秒前
sooooly发布了新的文献求助10
4秒前
yu晨发布了新的文献求助10
4秒前
4秒前
钟文发布了新的文献求助50
4秒前
舒适的秋尽发布了新的文献求助150
5秒前
5秒前
负责笑容发布了新的文献求助10
5秒前
麦豆腐德完成签到,获得积分10
5秒前
meng发布了新的文献求助10
6秒前
6秒前
随风发布了新的文献求助10
7秒前
时觉觉完成签到,获得积分10
7秒前
大雪纷飞发布了新的文献求助10
7秒前
7秒前
7秒前
领导范儿的应助被yjw0526采纳,获得10
8秒前
8秒前
一加一完成签到,获得积分10
8秒前
8秒前
8秒前
胖虎不胖发布了新的文献求助20
8秒前
无情的便当完成签到,获得积分10
9秒前
9秒前
w_w完成签到,获得积分20
9秒前
王可以发布了新的文献求助10
9秒前
10秒前
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178203
求助须知:如何正确求助?哪些是违规求助? 9568998
关于积分的说明 21802098
捐赠科研通 7773088
什么是DOI,文献DOI怎么找? 3432711
关于科研通互助平台的介绍 2556748
邀请新用户注册赠送积分活动 2478259